| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.
|
Arch Intern Med
|
2006
|
9.21
|
|
2
|
Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
|
J Natl Cancer Inst
|
2005
|
6.69
|
|
3
|
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study.
|
Lancet
|
2005
|
6.60
|
|
4
|
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
|
Clin Infect Dis
|
2005
|
3.57
|
|
5
|
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
|
Arch Intern Med
|
2003
|
3.41
|
|
6
|
Cohort profile: the Swiss HIV Cohort study.
|
Int J Epidemiol
|
2009
|
3.05
|
|
7
|
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission.
|
Clin Infect Dis
|
2006
|
2.93
|
|
8
|
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia.
|
J Infect Dis
|
2005
|
2.58
|
|
9
|
Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries.
|
Clin Infect Dis
|
2007
|
2.51
|
|
10
|
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study.
|
Clin Infect Dis
|
2005
|
2.35
|
|
11
|
Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland.
|
J Infect Dis
|
2010
|
2.21
|
|
12
|
Hodgkin lymphoma in the Swiss HIV Cohort Study.
|
Blood
|
2009
|
2.15
|
|
13
|
Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV Cohort Study.
|
Clin Infect Dis
|
2007
|
1.98
|
|
14
|
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2006
|
1.95
|
|
15
|
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.
|
Lancet
|
2003
|
1.94
|
|
16
|
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
|
J Infect Dis
|
2005
|
1.93
|
|
17
|
All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population.
|
AIDS
|
2004
|
1.91
|
|
18
|
Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival.
|
AIDS
|
2003
|
1.87
|
|
19
|
Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.
|
AIDS
|
2007
|
1.81
|
|
20
|
Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types.
|
Arch Intern Med
|
2007
|
1.80
|
|
21
|
Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks.
|
Int J Epidemiol
|
2002
|
1.79
|
|
22
|
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study.
|
AIDS
|
2002
|
1.75
|
|
23
|
Longitudinal analysis of patterns and predictors of changes in self-reported adherence to antiretroviral therapy: Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2010
|
1.75
|
|
24
|
Prevalence of unsafe sexual behavior among HIV-infected individuals: the Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2003
|
1.70
|
|
25
|
Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma.
|
AIDS
|
2008
|
1.66
|
|
26
|
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
|
AIDS
|
2008
|
1.60
|
|
27
|
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) /l.
|
AIDS
|
2002
|
1.38
|
|
28
|
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study.
|
Antivir Ther
|
2005
|
1.36
|
|
29
|
Infrequent transmission of HIV-1 drug-resistant variants.
|
Antivir Ther
|
2004
|
1.30
|
|
30
|
Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS).
|
Int J Epidemiol
|
2007
|
1.28
|
|
31
|
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.
|
J Acquir Immune Defic Syndr
|
2002
|
1.23
|
|
32
|
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modification.
|
Antivir Ther
|
2007
|
1.14
|
|
33
|
Predictors of hypertension and changes of blood pressure in HIV-infected patients.
|
Antivir Ther
|
2005
|
1.14
|
|
34
|
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome.
|
AIDS
|
2010
|
1.07
|
|
35
|
Migrants from sub-Saharan Africa in the Swiss HIV Cohort Study: a single center study of epidemiologic migration-specific and clinical features.
|
AIDS Patient Care STDS
|
2004
|
1.05
|
|
36
|
Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.
|
Clin Infect Dis
|
2008
|
1.02
|
|
37
|
Impact of previous virological treatment failures and adherence on the outcome of antiretroviral therapy in 2007.
|
PLoS One
|
2009
|
1.01
|
|
38
|
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study.
|
Antivir Ther
|
2010
|
1.00
|
|
39
|
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study.
|
Antivir Ther
|
2006
|
0.99
|
|
40
|
Kaposi sarcoma herpes virus antibody response and viremia following highly active antiretroviral therapy in the Swiss HIV Cohort study.
|
AIDS
|
2010
|
0.96
|
|
41
|
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortality.
|
AIDS
|
2015
|
0.95
|
|
42
|
Frequency of gynecologic follow-up and cervical cancer screening in the Swiss HIV cohort study.
|
J Acquir Immune Defic Syndr
|
2006
|
0.95
|
|
43
|
Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D:A:D) study.
|
Diabetes Care
|
2008
|
0.94
|
|
44
|
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study.
|
BMJ
|
2004
|
0.93
|
|
45
|
Impact of lamivudine on the risk of liver-related death in 2,041 HBsAg- and HIV-positive individuals: results from an inter-cohort analysis.
|
Antivir Ther
|
2006
|
0.92
|
|
46
|
Virological and immunological responses to efavirenz or boosted lopinavir as first-line therapy for patients with HIV.
|
Antivir Ther
|
2009
|
0.92
|
|
47
|
Is unsafe sexual behaviour increasing among HIV-infected individuals?
|
AIDS
|
2004
|
0.91
|
|
48
|
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study.
|
Antivir Ther
|
2007
|
0.91
|
|
49
|
Adherence to antiretroviral treatment decreases during postpartum compared to pregnancy: a longitudinal electronic monitoring study.
|
AIDS Patient Care STDS
|
2013
|
0.89
|
|
50
|
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children.
|
Arch Dis Child
|
2010
|
0.87
|
|
51
|
Long-term safety of discontinuation of secondary prophylaxis against Pneumocystis pneumonia: prospective multicentre study.
|
AIDS
|
2004
|
0.87
|
|
52
|
Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy.
|
PLoS One
|
2012
|
0.87
|
|
53
|
Predictors of HIV-protection behaviour in HIV-positive men who have sex with casual male partners: a test of the explanatory power of an extended Information-Motivation-Behavioural Skills model.
|
AIDS Care
|
2011
|
0.85
|
|
54
|
Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.
|
J Acquir Immune Defic Syndr
|
2013
|
0.84
|
|
55
|
Low postseroconversion CD4 count and rapid decrease of CD4 density identify HIV+ fast progressors.
|
AIDS Res Hum Retroviruses
|
2010
|
0.83
|
|
56
|
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study.
|
AIDS Res Hum Retroviruses
|
2010
|
0.83
|
|
57
|
High specificity of line-immunoassay based algorithms for recent HIV-1 infection independent of viral subtype and stage of disease.
|
BMC Infect Dis
|
2011
|
0.83
|
|
58
|
Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
|
Antivir Ther
|
2005
|
0.81
|
|
59
|
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection.
|
Antivir Ther
|
2004
|
0.80
|
|
60
|
Randomized trial of a computerized coronary heart disease risk assessment tool in HIV-infected patients receiving combination antiretroviral therapy.
|
Antivir Ther
|
2010
|
0.80
|
|
61
|
Sexual protection behavior in HIV-positive gay men: testing a modified information-motivation-behavioral skills model.
|
Arch Sex Behav
|
2010
|
0.79
|
|
62
|
Hierarchical modeling gave plausible estimates of associations between metabolic syndrome and components of antiretroviral therapy.
|
J Clin Epidemiol
|
2008
|
0.77
|
|
63
|
Ecological study of the predictors of successful management of dyslipidemia in HIV-infected patients on ART: the Swiss HIV Cohort Study.
|
HIV Clin Trials
|
2007
|
0.75
|
|
64
|
Essentials of good epidemiological practice.
|
Soz Praventivmed
|
2005
|
0.75
|
|
65
|
Parents living with HIV in a high-income country: do patients need specific support?
|
Swiss Med Wkly
|
2008
|
0.75
|
|
66
|
Rabbit retrotransposon sequences undetectable in blood donors and lymphoma patients of the Swiss HIV Cohort Study.
|
AIDS Res Hum Retroviruses
|
2006
|
0.75
|